AUROBINDO PHARMA LTD FDA Approval ANDA 216561

ANDA 216561

AUROBINDO PHARMA LTD

FDA Drug Application

Application #216561

Application Sponsors

ANDA 216561AUROBINDO PHARMA LTD

Marketing Status

Over-the-counter001

FDA Submissions

UNKNOWN; ORIG1TA2022-10-27STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

AUROBINDO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216561
            [companyName] => AUROBINDO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZELASTINE HYDROCHLORIDE","activeIngredients":"AZELASTINE HYDROCHLORIDE","strength":"205.5MCG","dosageForm":"SPRAY;NASAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/27\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-10-27
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.